Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease

Thomas M. Gorter, Masaru Obokata, Yogesh N.V. Reddy, Vojtech Melenovsky, Barry A Borlaug

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Aims Pulmonary hypertension (PH) and pulmonary vascular disease (PVD) are common and associated with adverse outcomes in heart failure with preserved ejection fraction (HFpEF). Little is known about the impact of PVD on the pathophysiology of exercise intolerance. Methods and results Heart failure with preserved ejection fraction patients (n = 161) with elevated pulmonary capillary wedge pressure (≥15 mmHg) at rest were classified into three groups: non-PH-HFpEF (n = 21); PH but no PVD (isolated postcapillary PH, IpcPH; n = 95); and PH with PVD (combined post- and pre-capillary PH, CpcPH; n = 45). At rest, CpcPH-HFpEF patients had more right ventricular (RV) dysfunction and lower pulmonary arterial (PA) compliance compared to all other groups. While right atrial pressure (RAP) and left ventricular transmural pressure (LVTMP) were similar in HFpEF with and without PH or PVD at rest, CpcPH-HFpEF patients demonstrated greater increase in RAP, enhanced ventricular interdependence, and paradoxical reduction in LVTMP during exercise, differing from all other groups (P < 0.05). Lower PA compliance was correlated with greater increase in RAP with exercise. During exercise, CpcPH-HFpEF patients displayed an inability to enhance cardiac output, reduction in forward stroke volume, and blunted augmentation in RV systolic performance, changes that were coupled with marked limitation in aerobic capacity. Conclusion Heart failure with preserved ejection fraction patients with PVD demonstrate unique haemodynamic limitations during exercise that constrain aerobic capacity, including impaired recruitment of LV preload due to excessive right heart congestion and blunted RV systolic reserve. Interventions targeted to this distinct pathophysiology require testing in patients with HFpEF and PVD.

Original languageEnglish (US)
Pages (from-to)2825-2835
Number of pages11
JournalEuropean Heart Journal
Volume39
Issue number30
DOIs
StatePublished - Aug 1 2018

Fingerprint

Vascular Diseases
Lung Diseases
Heart Failure
Exercise
Pulmonary Hypertension
Atrial Pressure
Lung Compliance
Ventricular Pressure
Right Ventricular Dysfunction
Pulmonary Wedge Pressure
Cardiac Output
Stroke Volume
Hemodynamics
Hypertension

Keywords

  • Heart failure with preserved ejection fraction
  • Invasive exercise haemodynamics
  • Pulmonary vascular disease
  • Right heart catheterization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease. / Gorter, Thomas M.; Obokata, Masaru; Reddy, Yogesh N.V.; Melenovsky, Vojtech; Borlaug, Barry A.

In: European Heart Journal, Vol. 39, No. 30, 01.08.2018, p. 2825-2835.

Research output: Contribution to journalArticle

Gorter, Thomas M. ; Obokata, Masaru ; Reddy, Yogesh N.V. ; Melenovsky, Vojtech ; Borlaug, Barry A. / Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease. In: European Heart Journal. 2018 ; Vol. 39, No. 30. pp. 2825-2835.
@article{75838dc4d3a94bcaa98337669c41e0f3,
title = "Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease",
abstract = "Aims Pulmonary hypertension (PH) and pulmonary vascular disease (PVD) are common and associated with adverse outcomes in heart failure with preserved ejection fraction (HFpEF). Little is known about the impact of PVD on the pathophysiology of exercise intolerance. Methods and results Heart failure with preserved ejection fraction patients (n = 161) with elevated pulmonary capillary wedge pressure (≥15 mmHg) at rest were classified into three groups: non-PH-HFpEF (n = 21); PH but no PVD (isolated postcapillary PH, IpcPH; n = 95); and PH with PVD (combined post- and pre-capillary PH, CpcPH; n = 45). At rest, CpcPH-HFpEF patients had more right ventricular (RV) dysfunction and lower pulmonary arterial (PA) compliance compared to all other groups. While right atrial pressure (RAP) and left ventricular transmural pressure (LVTMP) were similar in HFpEF with and without PH or PVD at rest, CpcPH-HFpEF patients demonstrated greater increase in RAP, enhanced ventricular interdependence, and paradoxical reduction in LVTMP during exercise, differing from all other groups (P < 0.05). Lower PA compliance was correlated with greater increase in RAP with exercise. During exercise, CpcPH-HFpEF patients displayed an inability to enhance cardiac output, reduction in forward stroke volume, and blunted augmentation in RV systolic performance, changes that were coupled with marked limitation in aerobic capacity. Conclusion Heart failure with preserved ejection fraction patients with PVD demonstrate unique haemodynamic limitations during exercise that constrain aerobic capacity, including impaired recruitment of LV preload due to excessive right heart congestion and blunted RV systolic reserve. Interventions targeted to this distinct pathophysiology require testing in patients with HFpEF and PVD.",
keywords = "Heart failure with preserved ejection fraction, Invasive exercise haemodynamics, Pulmonary vascular disease, Right heart catheterization",
author = "Gorter, {Thomas M.} and Masaru Obokata and Reddy, {Yogesh N.V.} and Vojtech Melenovsky and Borlaug, {Barry A}",
year = "2018",
month = "8",
day = "1",
doi = "10.1093/eurheartj/ehy331",
language = "English (US)",
volume = "39",
pages = "2825--2835",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "30",

}

TY - JOUR

T1 - Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease

AU - Gorter, Thomas M.

AU - Obokata, Masaru

AU - Reddy, Yogesh N.V.

AU - Melenovsky, Vojtech

AU - Borlaug, Barry A

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Aims Pulmonary hypertension (PH) and pulmonary vascular disease (PVD) are common and associated with adverse outcomes in heart failure with preserved ejection fraction (HFpEF). Little is known about the impact of PVD on the pathophysiology of exercise intolerance. Methods and results Heart failure with preserved ejection fraction patients (n = 161) with elevated pulmonary capillary wedge pressure (≥15 mmHg) at rest were classified into three groups: non-PH-HFpEF (n = 21); PH but no PVD (isolated postcapillary PH, IpcPH; n = 95); and PH with PVD (combined post- and pre-capillary PH, CpcPH; n = 45). At rest, CpcPH-HFpEF patients had more right ventricular (RV) dysfunction and lower pulmonary arterial (PA) compliance compared to all other groups. While right atrial pressure (RAP) and left ventricular transmural pressure (LVTMP) were similar in HFpEF with and without PH or PVD at rest, CpcPH-HFpEF patients demonstrated greater increase in RAP, enhanced ventricular interdependence, and paradoxical reduction in LVTMP during exercise, differing from all other groups (P < 0.05). Lower PA compliance was correlated with greater increase in RAP with exercise. During exercise, CpcPH-HFpEF patients displayed an inability to enhance cardiac output, reduction in forward stroke volume, and blunted augmentation in RV systolic performance, changes that were coupled with marked limitation in aerobic capacity. Conclusion Heart failure with preserved ejection fraction patients with PVD demonstrate unique haemodynamic limitations during exercise that constrain aerobic capacity, including impaired recruitment of LV preload due to excessive right heart congestion and blunted RV systolic reserve. Interventions targeted to this distinct pathophysiology require testing in patients with HFpEF and PVD.

AB - Aims Pulmonary hypertension (PH) and pulmonary vascular disease (PVD) are common and associated with adverse outcomes in heart failure with preserved ejection fraction (HFpEF). Little is known about the impact of PVD on the pathophysiology of exercise intolerance. Methods and results Heart failure with preserved ejection fraction patients (n = 161) with elevated pulmonary capillary wedge pressure (≥15 mmHg) at rest were classified into three groups: non-PH-HFpEF (n = 21); PH but no PVD (isolated postcapillary PH, IpcPH; n = 95); and PH with PVD (combined post- and pre-capillary PH, CpcPH; n = 45). At rest, CpcPH-HFpEF patients had more right ventricular (RV) dysfunction and lower pulmonary arterial (PA) compliance compared to all other groups. While right atrial pressure (RAP) and left ventricular transmural pressure (LVTMP) were similar in HFpEF with and without PH or PVD at rest, CpcPH-HFpEF patients demonstrated greater increase in RAP, enhanced ventricular interdependence, and paradoxical reduction in LVTMP during exercise, differing from all other groups (P < 0.05). Lower PA compliance was correlated with greater increase in RAP with exercise. During exercise, CpcPH-HFpEF patients displayed an inability to enhance cardiac output, reduction in forward stroke volume, and blunted augmentation in RV systolic performance, changes that were coupled with marked limitation in aerobic capacity. Conclusion Heart failure with preserved ejection fraction patients with PVD demonstrate unique haemodynamic limitations during exercise that constrain aerobic capacity, including impaired recruitment of LV preload due to excessive right heart congestion and blunted RV systolic reserve. Interventions targeted to this distinct pathophysiology require testing in patients with HFpEF and PVD.

KW - Heart failure with preserved ejection fraction

KW - Invasive exercise haemodynamics

KW - Pulmonary vascular disease

KW - Right heart catheterization

UR - http://www.scopus.com/inward/record.url?scp=85053413906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053413906&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehy331

DO - 10.1093/eurheartj/ehy331

M3 - Article

C2 - 29947750

AN - SCOPUS:85053413906

VL - 39

SP - 2825

EP - 2835

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 30

ER -